O00425 (IF2B3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 16, 2012.
Version 102.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Insulin-like growth factor 2 mRNA-binding protein 3 Short name=IGF2 mRNA-binding protein 3 Short name=IMP-3 Alternative name(s): IGF-II mRNA-binding protein 3 KH domain-containing protein overexpressed in cancer Short name=hKOC VICKZ family member 3 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 579 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | RNA-binding protein that act as a regulator of mRNA translation and stability. Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. Binds to sequences in the 3'-UTR of CD44 mRNA. Ref.13 |
| Subunit structure | Homodimer and multimer By similarity. Interacts with IGF2BP1. Ref.16 |
| Subcellular location | Nucleus. Cytoplasm. Note: Found in lamellipodia of the leading edge, in the perinuclear region, and beneath the plasma membrane. The subcytoplasmic localization is cell specific and regulated by cell contact and growth. Localized at the connecting piece and the tail of the spermatozoa. Colocalized with CD44 mRNA in RNP granules. Ref.6 Ref.9 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 |
| Tissue specificity | Expressed in fetal liver, fetal lung, fetal kidney, fetal thymus, fetal placenta, fetal follicles of ovary and gonocytes of testis, growing oocytes, spermatogonia and semen (at protein level). Expressed in cervix adenocarcinoma, in testicular, pancreatic and renal-cell carcinomas (at protein level). Expressed ubiquitously during fetal development at 8 and 14 weeks of gestation. Expressed in ovary, testis, brain, placenta, pancreatic cancer tissues and pancreatic cancer cell lines. Ref.1 Ref.5 Ref.6 Ref.8 Ref.11 Ref.12 Ref.14 Ref.15 |
| Domain | The third and fourth KH domains are important for binding to the untranslated region (UTR) of target mRNA. Ref.19 |
| Miscellaneous | Autoantibodies against IGF2BP3 are detected in sera from some patients with a variety of carcinomas. |
| Sequence similarities | Belongs to the RRM IMP/VICKZ family. Contains 4 KH domains. Contains 2 RRM (RNA recognition motif) domains. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O00425-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O00425-2) The sequence of this isoform differs from the canonical sequence as follows: 1-381: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||
Molecule processing | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 579 | 579 | Insulin-like growth factor 2 mRNA-binding protein 3 | PRO_0000282538 | ||||||||||||||||||
Regions | ||||||||||||||||||||||
| Domain | 2 – 75 | 74 | RRM 1 | |||||||||||||||||||
| Domain | 81 – 156 | 76 | RRM 2 | |||||||||||||||||||
| Domain | 195 – 260 | 66 | KH 1 | |||||||||||||||||||
| Domain | 276 – 343 | 68 | KH 2 | |||||||||||||||||||
| Domain | 405 – 470 | 66 | KH 3 | |||||||||||||||||||
| Domain | 487 – 553 | 67 | KH 4 | |||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||
| Modified residue | 528 | 1 | Phosphothreonine Ref.17 Ref.18 | |||||||||||||||||||
Natural variations | ||||||||||||||||||||||
| Alternative sequence | 1 – 381 | 381 | Missing in isoform 2. | VSP_024172 | ||||||||||||||||||
Experimental info | ||||||||||||||||||||||
| Sequence conflict | 410 | 1 | L → Q in AAD09223. Ref.1 | |||||||||||||||||||
| Sequence conflict | 410 | 1 | L → Q in AAC35208. Ref.1 | |||||||||||||||||||
| Sequence conflict | 494 | 1 | V → A in CAH56186. Ref.2 | |||||||||||||||||||
Secondary structure | ||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||
| Beta strand | 83 – 88 | 6 | ||||||||||||||||||||
| Beta strand | 90 – 92 | 3 | ||||||||||||||||||||
| Helix | 94 – 104 | 11 | ||||||||||||||||||||
| Beta strand | 107 – 113 | 7 | ||||||||||||||||||||
| Beta strand | 116 – 128 | 13 | ||||||||||||||||||||
| Helix | 129 – 139 | 11 | ||||||||||||||||||||
| Beta strand | 150 – 153 | 4 | ||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein." Mueller-Pillasch F., Lacher U., Wallrapp C., Micha A., Zimmerhackl F., Hameister H., Varga G., Friess H., Buechler M., Beger H.G., Vila M.R., Adler G., Gress T.M. Oncogene 14:2729-2733(1997) [PubMed: 9178771] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY. Tissue: Pancreas and Pancreatic cancer. |
| [2] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Endometrial tumor. |
| [3] | "The DNA sequence of human chromosome 7." Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L. Wilson R.K.Nature 424:157-164(2003) [PubMed: 12853948] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Eye. |
| [5] | "Expression of the highly conserved RNA binding protein KOC in embryogenesis." Mueller-Pillasch F., Pohl B., Wilda M., Lacher U., Beil M., Wallrapp C., Hameister H., Knoechel W., Adler G., Gress T.M. Mech. Dev. 88:95-99(1999) [PubMed: 10525192] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [6] | "A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development." Nielsen J., Christiansen J., Lykke-Andersen J., Johnsen A.H., Wewer U.M., Nielsen F.C. Mol. Cell. Biol. 19:1262-1270(1999) [PubMed: 9891060] [Abstract] Cited for: GENE NOMENCLATURE, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, RNA-BINDING. |
| [7] | "Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies." Zhang J.-Y., Chan E.K., Peng X.-X., Lu M., Wang X., Mueller F., Tan E.M. Clin. Immunol. 100:149-156(2001) [PubMed: 11465943] [Abstract] Cited for: IDENTIFICATION AS A CARCINOMA ANTIGEN. |
| [8] | "Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome." Monk D., Bentley L., Beechey C., Hitchins M., Peters J., Preece M.A., Stanier P., Moore G.E. J. Med. Genet. 39:575-581(2002) [PubMed: 12161597] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [9] | "Nuclear transit of human zipcode-binding protein IMP1." Nielsen J., Adolph S.K., Rajpert-De Meyts E., Lykke-Andersen J., Koch G., Christiansen J., Nielsen F.C. Biochem. J. 376:383-391(2003) [PubMed: 12921532] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [10] | "VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins." Yisraeli J.K. Biol. Cell 97:87-96(2005) [PubMed: 15601260] [Abstract] Cited for: REVIEW. |
| [11] | "KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas." Yantiss R.K., Woda B.A., Fanger G.R., Kalos M., Whalen G.F., Tada H., Andersen D.K., Rock K.L., Dresser K. Diagn. Mol. Pathol. 29:188-195(2005) [PubMed: 15644775] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [12] | "Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer." Hammer N.A., Hansen T.O., Byskov A.G., Rajpert-De Meyts E., Groendahl M.L., Bredkjaer H.E., Wewer U.M., Christiansen J., Nielsen F.C. Reproduction 130:203-212(2005) [PubMed: 16049158] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [13] | "RNA-binding IMPs promote cell adhesion and invadopodia formation." Vikesaa J., Hansen T.V., Joenson L., Borup R., Wewer U.M., Christiansen J., Nielsen F.C. EMBO J. 25:1456-1468(2006) [PubMed: 16541107] [Abstract] Cited for: FUNCTION, RNA-BINDING, SUBCELLULAR LOCATION. |
| [14] | "Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study." Jiang Z., Chu P.G., Woda B.A., Rock K.L., Liu Q., Hsieh C.-C., Li C., Chen W., Duan H.O., McDougal S., Wu C.-L. Lancet Oncol. 7:556-564(2006) [PubMed: 16814207] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [15] | "IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression." Li C., Rock K.L., Woda B.A., Jiang Z., Fraire A.E., Dresser K. Mod. Pathol. 20:242-247(2007) [PubMed: 17192788] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [16] | "Molecular composition of IMP1 ribonucleoprotein granules." Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R., Johnsen A.H., Christiansen J., Nielsen F.C. Mol. Cell. Proteomics 6:798-811(2007) [PubMed: 17289661] [Abstract] Cited for: INTERACTION WITH IGF2BP1. |
| [17] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-528, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-528, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [19] | "ZBP1 recognition of beta-actin zipcode induces RNA looping." Chao J.A., Patskovsky Y., Patel V., Levy M., Almo S.C., Singer R.H. Genes Dev. 24:148-158(2010) [PubMed: 20080952] [Abstract] Cited for: RNA-BINDING, DOMAIN. |
| [20] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [21] | "Solution structure of RNA binding domain in insulin-like growth factor 2 mRNA-binding protein 3." RIKEN structural genomics initiative (RSGI) Submitted (JUN-2007) to the PDB data bank Cited for: STRUCTURE BY NMR OF 73-161. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U76705 mRNA. Translation: AAD09223.1. U97188 mRNA. Translation: AAC35208.1. BX640800 mRNA. Translation: CAE45883.1. BX648488 mRNA. Translation: CAH56186.1. AC005082 Genomic DNA. No translation available. AC021876 Genomic DNA. No translation available. AC079780 Genomic DNA. No translation available. BC065269 mRNA. Translation: AAH65269.1. | ||||||||||||
| IPI | IPI00165467. IPI00658000. | ||||||||||||
| RefSeq | NP_006538.2. NM_006547.2. | ||||||||||||
| UniGene | Hs.700696. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | O00425. | ||||||||||||
| SMR | O00425. Positions 1-161, 194-562. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | O00425. 7 interactions. | ||||||||||||
| STRING | O00425. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | O00425. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | O00425. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000258729; ENSP00000258729; ENSG00000136231. | ||||||||||||
| GeneID | 10643. | ||||||||||||
| KEGG | hsa:10643. | ||||||||||||
| UCSC | uc003swf.3. human. uc003swg.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 10643. | ||||||||||||
| GeneCards | GC07M023316. | ||||||||||||
| HGNC | HGNC:28868. IGF2BP3. | ||||||||||||
| HPA | HPA002037. | ||||||||||||
| MIM | 608259. gene. | ||||||||||||
| neXtProt | NX_O00425. | ||||||||||||
| PharmGKB | PA128394576. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG249985. | ||||||||||||
| GeneTree | ENSGT00530000063171. | ||||||||||||
| HOGENOM | HOG000000675. | ||||||||||||
| HOVERGEN | HBG052725. | ||||||||||||
| InParanoid | O00425. | ||||||||||||
| KO | K13197. | ||||||||||||
| OMA | IKEENFV. | ||||||||||||
| OrthoDB | EOG405S0T. | ||||||||||||
| PhylomeDB | O00425. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_116125. Disease. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | O00425. | ||||||||||||
| Bgee | O00425. | ||||||||||||
| CleanEx | HS_IGF2BP3. HS_IMP3. | ||||||||||||
| Genevestigator | O00425. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | G3DSA:3.30.70.330. a_b_plait_nuc_bd. 1 hit. | ||||||||||||
| InterPro | IPR004087. KH_dom. IPR004088. KH_dom_type_1. IPR012677. Nucleotide-bd_a/b_plait. IPR000504. RRM_dom. [Graphical view] | ||||||||||||
| Pfam | PF00013. KH_1. 4 hits. PF00076. RRM_1. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00322. KH. 4 hits. SM00360. RRM. 2 hits. [Graphical view] | ||||||||||||
| PROSITE | PS50084. KH_TYPE_1. 4 hits. PS50102. RRM. 2 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | O00425. | ||||||||||||
| NextBio | 40451. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | IF2B3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O00425 Secondary accession number(s): A0A4Z5 Q86VB1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with